ULTRASCULPT JOURNAL · FOR PRACTITIONERS Low-Frequency Ultrasound and Cellular Senescence: A Research Brief for Physicians Cellular Senescence · Mechanobiology · Published Research By UltraSculpt · Educational article Illustrative laboratory scene with a researcher examining conceptual cell imagery; not a photograph of the cited study. Published literature gives physicians a source they can examine directly when patients ask about cellular aging and ultrasound. This brief introduces a peer-reviewed paper and separates its experimental observations from the evidence needed for clinical decisions. The paper to read Kureel and colleagues’ Rejuvenation of Senescent Cells, In Vitro and In Vivo, by Low-Frequency Ultrasound appeared in Aging Cell, 24(6), e70008; first published March 3, 2025. DOI: 10.1111/acel.70008. Read the open-access paper. Experimental design and findings The investigators studied chemically induced and replicative senescence in cell cultures, alongside mouse experiments. Their optimized exposure used 32.2 kHz, 4 kPa, 30 minutes and alternating 1.5-second on/off intervals. They reported restored proliferation and changes in senescence-associated markers and secretory activity. Mechanistic experiments implicated Piezo1, calcium signaling, Sirtuin1, autophagy and mTORC1. These parameters describe the research apparatus, not instructions for an UltraSculpt treatment. Clinical translation: what needs to be established? This paper provides preclinical evidence, not a human UltraSculpt skin-tightening trial. A clinical interpretation requires matching device output, dosimetry, tissue exposure and protocol, then evaluating human safety, efficacy and durability. A shared ultrasound frequency or treatment duration alone does not establish equivalence. For a practice evaluating a treatment, useful evidence would include the specific device and skincare protocol, defined patient population, comparator, validated clinical endpoints, follow-up and adverse-event reporting. Visible appearance outcomes and cellular biomarkers answer different questions; each needs its own supporting data. Why this belongs in a physician conversation The article makes the scientific question accessible for independent review. Physicians can examine methods and discuss its relevance without having to rely solely on a sales explanation. The paper also discloses patent and commercial interests among some authors; review that disclosure alongside the results. At UltraSculpt, we connect professional questions with our team and founder and inventor Dr. Joanne Jiang. This is an editorial research brief, not a claim that Joanne authored this paper or reviewed this article. Explore UltraSculpt’s technology or professional partnership support. For a client-friendly explanation, see What Are “Zombie Cells”?. Any questions or comments: Call or text 609-507-0620. Call UltraSculpt or send a text. Explore frequently asked questions · Learn about the technology
